dextromethorphan teva 1,5 mg/ml or. sol.
teva pharma belgium sa-nv - dextromethorphan hydrobromide 1,5 mg/ml - oral solution - 1,5 mg/ml - dextromethorphan hydrobromide 1.5 mg/ml - dextromethorphan
congecaf 325mg/ 10mg/ 1mg/ 15mg capsule
yunimedika philippines, inc. - paracetamol / phenylpropanolamine hcl / chlorpheniramine maleate / dextromethorphan hbr - capsule - 325mg/ 10mg/ 1mg/ 15mg
cinquesaph capsule
n/a; importer: nelpa lifesciences, inc.; distributor: nelpa lifesciences, inc. - paracetamol , guaifenesin , phenylpropanolamine hydrochloride , dextromethorphan hydrobromide , chlorphenamine maleate - capsule - formulation: each capsule contains: paracetamol-325mg guaifenesin-50mg phenylpropanolamine hydrochloride-12.5mg dextromethorphan hydrobromide-10mg chlorphenamine maleate-1mg
dextromethorphan hydrobromide lozenges
unique pharmaceutical laboratories unique pharmaceutical laboratories - dextromethorphan hydrobromide - lozenge - dextromethorphan hydrobromide 10mg - cough suppressants excluding combinations with
broncotron d- guaifenesin, dextromethorphan, phenyphrine hydrchloride liquid
seyer pharmatec, inc. - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - guaifenesin 200 mg in 5 ml - uses - helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes. - temporarily relieves cough due to minor throat and bronchial irritations as may occur with the common cold. - temporarily relieves nasal congestions due to the common cold. do not use other information: - warning: phenylketonurics: contains phenylalanine 15 mg per 5 ml - store at 15-30 degree celsius(59-86 degree farenheit) - alcohol free and phenylpropanolamine(ppa) free
promethazine dm- dextromethorphan hydrobromide and promethazine hydrochloride solution
nucare pharmaceuticals,inc. - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide oral solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.
promethazine dm- dextromethorphan hydrobromide and promethazine hydrochloride syrup
aidarex pharmaceuticals llc - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. promethazine products are contraindicated for use in pediatric patients less than two years of age. caution should be exercised when administering promethazine products to pediatric patients 2 years of age and older because of the potential for fatal respiratory depression. respiratory depression and apnea, sometimes associated with death, are strongly associated with promethazine products and are n
promethazine dm- dextromethorphan hydrobromide and promethazine hydrochloride solution
proficient rx lp - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions,drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. promethazine products are contraindicated for use in pediatric patients less than two years of age. caution should be exercised when administering promethazine products to pediatric patients 2 years of age and older because of the potential for fatal respiratory depression. respiratory depression and apnea, sometimes associated with death, are strongly associated with promethazine products and are no
promethazine dm- dextromethorphan hydrobromide and promethazine hydrochloride solution
remedyrepack inc. - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide oral solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.
promethazine dm- dextromethorphan hydrobromide and promethazine hydrochloride solution
par pharmaceutical - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide oral solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.